Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns
Owen Dyer
Abstract
FDA expert panel recommends authorising molnupiravir but
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Panel discussionMedicineVirologyBusinessAdvertisingInfectious disease (medical specialty)OutbreakPathologyDiseaseSARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research StudiesRespiratory viral infections research